Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Vishay Intertechnology enters the final stretch before its November 4 earnings with an unusual combination: a stock up 13% on the week, short interest still elevated at 13.5% of the float, and a fresh wave of analyst upgrades pushing the consensus target above the current price for the first time in years.
The positioning picture is split between a high but retreating short base and a lending market that remains remarkably relaxed. Short interest has edged lower over the past week, falling roughly 2.6% to around 16.7 million shares, or 13.5% of free float. Over the past month it has risen 19%, so the longer-term build is still in place even as the near-term trend turns softer. The borrow, however, does not look squeezed. Availability is running near 595%, meaning there are roughly six shares available to borrow for every one currently lent out, and even at its tightest point over the past year that ratio never fell below 200%. Cost to borrow has lifted 51% on the week to 0.55%, but that still counts as a low-cost borrow in absolute terms. The options market is similarly calm: the put/call ratio sits at 0.64, a fraction below its 20-day average of 0.69 and well clear of the spike to 1.14 seen on September 28. That spike looks like a one-session anomaly. None of this signals imminent squeeze pressure.
The Street angle is where the note gets more interesting. Four separate coverage initiations since early August have all come in bullish: Oppenheimer (Outperform, $42 target, initiated September 15), Truist Securities (Buy, $42, September 3), Raymond James (Outperform, $40, August 4), and Needham (Buy, $45, August 4). This morning Oppenheimer raised its target from $42 to $45, the freshest move in the data. At $36.87, the mean analyst target of $40.50 implies around 10% upside, which is a meaningful premium but not a stretched one given how far the stock has run. The outlier remains BofA, which holds an Underperform with a $28 target raised back in May, when the stock traded near $18. That target now sits more than 24% below the current price, a gap that tells its own story about how fast sentiment has shifted. On valuation, the P/E has expanded to 24x, up around 2.5 turns over the past 30 days, while EV/EBITDA has eased slightly to 9.6x. Neither multiple looks stretched for a passive components maker catching a cycle recovery, but the EV/EBIT factor score ranks in just the 10th percentile, a reminder that operating leverage is still thin. EPS momentum over 30 days ranks in the 84th percentile and the analyst recommendation divergence score is at the 94th, the two most powerful positives in the factor profile.
The ownership data adds context to the short interest read. BlackRock lifted its stake by nearly 2 million shares as of September 30, taking its holding to 13.2% of shares outstanding, the largest single block in the register. Point72 added more than 3 million shares as of June 30 to reach 3.2%, and Neuberger Berman effectively built a fresh position of nearly 3 million shares over the same period. On the other side of the ledger, a director sold roughly 16,600 shares on October 2 under a pre-arranged 10b5-1 plan, generating about $594,000. Planned sales carry less signal than discretionary ones, but it is the only open-market trade in the recent data. Retail attention is also above normal: Wikipedia page views are running 1.3 standard deviations above their 90-day average, a signal that the 13-week, 156% year-to-date run is drawing fresh eyes.
The prior earnings print is worth registering. On August 5, the stock fell 15.6% on the day and gave back 13.6% over the following week, a punishing reaction that preceded the current recovery. The next scheduled print is November 4. Close peers KN and VPG gained 2.5% and 3.6% respectively on the week against VSH's 13.3%, suggesting the move carries a company-specific catalyst rather than pure sector rotation. Both gave back roughly 3% on Wednesday alongside VSH's 2.6% single-day pullback, which kept the relative outperformance intact.
The tension to watch going into November 4 is whether the rebuilt short position, still 13.5% of float with a month-long accumulation behind it, reflects genuine fundamental skepticism about a sequential recovery, or simply a lag before covering accelerates into the print.
See the live data behind this article on ORTEX.
Open VSH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
